Heart rate and outcome in heart failure with reduced ejection fraction: Differences between atrial fibrillation and sinus rhythm-A CIBIS II analysis

Clin Cardiol. 2017 Sep;40(9):740-745. doi: 10.1002/clc.22725. Epub 2017 May 17.

Abstract

Background: Heart rate has been associated with prognosis in patients with heart failure with reduced ejection fraction (HFREF) and sinus rhythm; whether this also holds true in patients with atrial fibrillation (AF) is unknown.

Hypothesis: To evaluate cardiac rhythm and baseline heart rate and the influence of outcome in patients with HFREF enrolled in the Cardiac Insufficiency Bisoprolol Study II.

Methods: In total, 2539 patients were stratified according to their baseline heart rhythm (AF or sinus rhythm) and into quartiles of heart rate (≤70 bpm, 71-78 bpm, 79-90 bpm, and >90 bpm). The primary outcome was all-cause mortality. Mean follow-up was 1.3 years.

Results: Mean age was 61 years, mean left ventricular ejection fraction was 28%, and 80% were male. A total of 521 (21%) patients had AF at baseline. The risk associated with all-cause mortality for each 5 bpm increase in heart rate in patients with sinus rhythm (hazard ratio [HR]: 1.06, 95% confidence interval [CI]: 1.01-1.11, P = 0.012) was significantly different from those with AF (HR: 1.00, 95% CI: 0.94-1.07, P = 0.90, P for interaction = 0.041). The risk associated with higher heart rate in sinus rhythm was primarily attributable to excess risk in the highest quartile (HR: 1.64, 95% CI: 1.18-2.30, P = 0.003). Allocation to bisoprolol did not modify the interaction between heart rate, rhythm and outcome.

Conclusions: In HFREF patients with AF, a higher heart rate is not associated with increased event rates in contrast to HFREF patients with sinus rhythm.

Keywords: Atrial Fibrillation; Bisoprolol; Cardiovascular Outcome; Heart Failure; Heart Rate.

Publication types

  • Comparative Study
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Adrenergic beta-1 Receptor Antagonists / therapeutic use
  • Aged
  • Atrial Fibrillation / diagnosis
  • Atrial Fibrillation / drug therapy
  • Atrial Fibrillation / mortality
  • Atrial Fibrillation / physiopathology*
  • Bisoprolol / therapeutic use
  • Double-Blind Method
  • Europe
  • Female
  • Heart Failure / diagnosis
  • Heart Failure / drug therapy
  • Heart Failure / mortality
  • Heart Failure / physiopathology*
  • Heart Rate* / drug effects
  • Humans
  • Male
  • Middle Aged
  • Risk Factors
  • Stroke Volume*
  • Time Factors
  • Treatment Outcome
  • Ventricular Function, Left*

Substances

  • Adrenergic beta-1 Receptor Antagonists
  • Bisoprolol